InSite Vision Inc (ISV) Stock Quote
Get the latest ISV - InSite Vision Inc stock market performance data and financial news.
InSite Vision Inc (ISV) Community Sentiment
Get the latest ISV - InSite Vision Inc together with stock market performance data and financial news.
InSite Vision Inc (ISV) Stock Quote
Get the latest ISV - InSite Vision Inc stock market performance data and financial news.
Jim Cramer's Take on InSite Vision Inc
Read Jim Cramer's take on InSite Vision Inc (ISV) and get his latest thoughts on the company?s performance and outlook
Financial Portfolio on Recent Stock Quotes & Stock Market Picks ...
Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
Gold Funds Stall as Dollar Steadies
The average precious metals fund tracked by TheStreet.com Ratings lost 8.47% of its value over the week ended Thursday.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10390621/1/gold-funds-stall-as-dollar-steadies.html
Friday's Early Winners & Losers
Shares of InSite Vision rise on reports of a patent agreement with Pfizer.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10339212/1/fridays-early-winners-losers.html
Monday's Health Winners & Losers
InSite Vision climbs, but Epix falls.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10306095/1/mondays-health-winners-losers.html
10 Questions: Prudent Bear Fund Manager David Tice
Skepticism has never been so profitable.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10020816/1/10-questions-prudent-bear-fund-manager-david-tice.html
RealMoney.com: Friday's Health Winners & Losers
... Friday include Sunesis Pharmaceuticals (SNSS - commentary - Cramer's Take), down
1% to $5.44; eye-drug developer InSite Vision (ISV - commentary - Cramer's Take ...
http://www.thestreet.com/p/newsanalysis/winnershealth/10296934_2.html
Connect with TheStreet